Key result
Hypertensive disorders of pregnancy with CVD raise severe maternal morbidity, peaking at ~33% in pulmonary hypertension.
Why the study?
Limited data have evaluated how hypertensive disorders of pregnancy influence non-transfusion severe maternal morbidity across specific cardiovascular disease subtypes during delivery and through the postpartum period in large contemporary U.S. cohorts.
Does the presence of hypertensive disorders of pregnancy increase the risk of non-transfusion severe maternal morbidity during delivery and within 90 days postpartum among pregnant patients with specific cardiovascular disease subtypes?
Cohort (n=4,606,247)
Yes
Does the presence of hypertensive disorders of pregnancy increase the risk of non-transfusion severe maternal morbidity during delivery and within 90 days postpartum among pregnant patients with specific cardiovascular disease subtypes?
Answers are grounded in this paper and cite their sources.
Hypertensive disorders of pregnancy substantially amplify the risk of non-transfusion severe maternal morbidity, ICU admission, and postpartum readmission in patients with underlying cardiovascular disease, especially those with pulmonary hypertension or cardiomyopathy.
BACKGROUND: Cardiovascular disease (CVD) and hypertensive disorders of pregnancy (HDP) are independently associated with increased risk of severe maternal morbidity (SMM). While prior studies have characterized adverse pregnancy outcomes among patients with CVD, limited data have evaluated how the development of HDP influences non-transfusion SMM across specific cardiac subtypes, particularly through the postpartum period, in large contemporary U.S. cohorts. OBJECTIVE: To assess the impact of HDP on non-transfusion SMM among patients with CVD during delivery and within 90 days postpartum. STUDY DESIGN: Retrospective cohort study using the Premier Healthcare Database of pregnant patients ≥18 years delivering between 2015 and 2020. Patients without CVD were compared to those with six CVD subtypes present on admission (aortic, ischemic, congenital, pulmonary hypertension, cardiomyopathy, and valvular). The primary outcome was non-transfusion SMM during delivery hospitalization and within 90 days postpartum, stratified by CVD and HDP subtype (gestational hypertension, preeclampsia, and preeclampsia with severe features), estimated as covariate-adjusted predicted rates (%). Secondary outcomes included SMM subtypes, ICU admission, and all-cause readmission within 30 and 90 days, reported as crude rates and adjusted odds ratios (aORs). RESULTS: Of 4,606,247 births, 18,771 (0.4%) had CVD, and 12.0% had HDP. HDP was associated with higher adjusted predicted non-transfusion SMM rates, independent of CVD, with increasing risk across HDP severity and marked heterogeneity by CVD subtype. Patients with CVD had consistently higher SMM across all HDP subtypes. The highest delivery hospitalization SMM rates occurred among patients with cardiomyopathy (25.6%) and pulmonary hypertension (33.2%) with preeclampsia with severe features; this pattern persisted through 90 days postpartum. Acute respiratory distress syndrome and mechanical ventilation were the most common SMM types during delivery, while heart failure/pulmonary edema predominated postpartum. Cardiomyopathy (aOR 9.02) and pulmonary hypertension (aOR 4.37) had the highest odds of ICU admission; readmission risk was also highest in pulmonary hypertension (30-day aOR 1.77; 90-day aOR 1.76) and cardiomyopathy (30-day aOR 1.42; 90-day aOR 1.68). CONCLUSION: HDP significantly increases risk of non-transfusion SMM in patients with CVD, particularly in pulmonary hypertension and cardiomyopathy, and in those with preeclampsia with severe features.
No takes yet. Share an insight, caveat, or question.
Jones et al. (2026) conducted a cohort in Cardiovascular disease and hypertensive disorders of pregnancy (n=4,606,247). Cardiovascular disease subtypes (aortic, ischemic, congenital, pulmonary hypertension, cardiomyopathy, valvular) and hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, preeclampsia with severe features) vs. Pregnant patients without cardiovascular disease or hypertensive disorders of pregnancy was evaluated on Non-transfusion severe maternal morbidity (SMM) during delivery hospitalization and within 90 days postpartum. Hypertensive disorders of pregnancy with CVD increased non-transfusion SMM, peaking in pulmonary hypertension and cardiomyopathy with severe preeclampsia.
Synapse has enriched 10 related papers. Consider them for comparative context: